Cargando…
miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects 5–20% of women of reproductive age. Interestingly, serum miR-124-3p and ANGPTL2 are differentially expressed in PCOS patients. Accordingly, this study set out to explore the clinical roles of serum miR-124-3p/ANGPTL2 in PCOS. First...
Autores principales: | Dai, Hongmei, Liu, Fangting, Lu, Jianshu, Yang, Yan, Liu, Pingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213205/ https://www.ncbi.nlm.nih.gov/pubmed/35747760 http://dx.doi.org/10.1155/2022/2155018 |
Ejemplares similares
-
Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017) -
Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023) -
Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome
por: Satyaraddi, Anil, et al.
Publicado: (2019) -
Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome
por: Pokorska-Niewiada, Kamila, et al.
Publicado: (2022) -
Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis
por: Lin, Kainan, et al.
Publicado: (2021)